Saroglitazar in Non-alcoholic Fatty Liver Disease From Bench to Bedside: A Comprehensive Review and Sub-group Meta-Analysis

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of liver diseases globally, with a projected exponential rise. In contrast to the exponential rise in disease burden, there are limited options in the pharmacotherapeutic armamentarium against NAFLD. Saroglitazar belo...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Akash, Tewari, Bikram, Giri, Suprabhat, Goenka, Mahesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663873/
https://www.ncbi.nlm.nih.gov/pubmed/38022283
http://dx.doi.org/10.7759/cureus.47493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663873/
https://www.ncbi.nlm.nih.gov/pubmed/38022283
http://dx.doi.org/10.7759/cureus.47493

Ejemplares similares